TrialRadiation oncology (London, England)2017

A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.

Yi Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.